PROTECT

Serial Number 79392943
Registration 7592796
700

Registration Progress

Application Filed
Jan 24, 2024
Under Examination
Approved for Publication
Sep 18, 2024
Published for Opposition
Oct 8, 2024
Registered
Dec 10, 2024

Trademark Image

PROTECT

Basic Information

Serial Number
79392943
Registration Number
7592796
Filing Date
January 24, 2024
Registration Date
December 10, 2024
Published for Opposition
October 8, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 10, 2024
Registration
Registered
Classes
042 045

Rights Holder

Zymeworks BC Inc.

03
Address
Suite 800 - 114 East 4th Avenue
Vancouver BC V5T 1G4
CA

Ownership History

Zymeworks BC Inc.

Original Applicant
03
CA

Zymeworks BC Inc.

Owner at Publication
03
CA

Zymeworks BC Inc.

Original Registrant
03
CA

USPTO Deadlines

Next Deadline
1952 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-10)
Due Date
December 10, 2030
Grace Period Ends
June 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

12 events
Date Code Type Description Documents
Jan 9, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Dec 10, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 8, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 18, 2024 NPUB O NOTICE OF PUBLICATION Loading...
Aug 30, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 19, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 5, 2024 CORR I CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED Loading...
May 12, 2024 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Apr 13, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 9, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 8, 2024 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Apr 4, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 042
Scientific research and development of preparations, agents and technology for the development of antibody therapeutics all for the treatment, and prophylaxis of human diseases, disorders and conditions, namely, cancer, autoimmune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, autoimmune diseases, inflammatory diseases, and infectious diseases
Class 045
Licensing of intellectual property

Classification

International Classes
042 045